147 related articles for article (PubMed ID: 34832846)
21. Peptide/Lipid-Associated Nucleic Acids (PLANAs) as a Multicomponent siRNA Delivery System.
Hall R; Alasmari A; Mozaffari S; Mahdipoor P; Parang K; Montazeri Aliabadi H
Mol Pharm; 2021 Mar; 18(3):986-1002. PubMed ID: 33496597
[TBL] [Abstract][Full Text] [Related]
22. Systemic and tumor-targeted delivery of siRNA by cyclic NGR and isoDGR motif-containing peptides.
Huang Y; Cheng Q; Jin X; Ji JL; Guo S; Zheng S; Wang X; Cao H; Gao S; Liang XJ; Du Q; Liang Z
Biomater Sci; 2016 Mar; 4(3):494-510. PubMed ID: 26783563
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
24. Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes.
Alkaraki A; Alshaer W; Wehaibi S; Gharaibeh L; Abuarqoub D; Alqudah DA; Al-Azzawi H; Zureigat H; Souleiman M; Awidi A
Breast Cancer; 2020 Sep; 27(5):989-998. PubMed ID: 32328816
[TBL] [Abstract][Full Text] [Related]
25. Tumor-targeted pH-low insertion peptide delivery of theranostic gadolinium nanoparticles for image-guided nanoparticle-enhanced radiation therapy.
Liu W; Deacon J; Yan H; Sun B; Liu Y; Hegan D; Li Q; Coman D; Parent M; Hyder F; Roberts K; Nath R; Tillement O; Engelman D; Glazer P
Transl Oncol; 2020 Nov; 13(11):100839. PubMed ID: 32763504
[TBL] [Abstract][Full Text] [Related]
26. Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovarian Cancer Cell Lines.
Mandal D; Lohan S; Sajid MI; Alhazza A; Tiwari RK; Parang K; Montazeri Aliabadi H
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839988
[TBL] [Abstract][Full Text] [Related]
27. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
[TBL] [Abstract][Full Text] [Related]
28. Green Synthesis of Sub-10 nm Gadolinium-Based Nanoparticles for Sparkling Kidneys, Tumor, and Angiogenesis of Tumor-Bearing Mice in Magnetic Resonance Imaging.
Zhang B; Yang W; Yu J; Guo W; Wang J; Liu S; Xiao Y; Shi D
Adv Healthc Mater; 2017 Feb; 6(4):. PubMed ID: 28004887
[TBL] [Abstract][Full Text] [Related]
29. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
Liu CW; Lin WJ
J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
[TBL] [Abstract][Full Text] [Related]
30. Efficient Intracellular Delivery of Cell-Impermeable Cargo Molecules by Peptides Containing Tryptophan and Histidine.
Shirazi AN; Mozaffari S; Sherpa RT; Tiwari R; Parang K
Molecules; 2018 Jun; 23(7):. PubMed ID: 29949881
[TBL] [Abstract][Full Text] [Related]
31. Gadolinium loaded nanoparticles in theranostic magnetic resonance imaging.
Liu Y; Zhang N
Biomaterials; 2012 Jul; 33(21):5363-75. PubMed ID: 22521487
[TBL] [Abstract][Full Text] [Related]
32. A systematic comparison of lipopolymers for siRNA delivery to multiple breast cancer cell lines: In vitro studies.
Aliabadi HM; Bahadur K C R; Bousoik E; Hall R; Barbarino A; Thapa B; Coyle M; Mahdipoor P; Uludağ H
Acta Biomater; 2020 Jan; 102():351-366. PubMed ID: 31760224
[TBL] [Abstract][Full Text] [Related]
33. Gadolinium nanoparticles and contrast agent as radiation sensitizers.
Taupin F; Flaender M; Delorme R; Brochard T; Mayol JF; Arnaud J; Perriat P; Sancey L; Lux F; Barth RF; Carrière M; Ravanat JL; Elleaume H
Phys Med Biol; 2015 Jun; 60(11):4449-64. PubMed ID: 25988839
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis, and Evaluation of Homochiral Peptides Containing Arginine and Histidine as Molecular Transporters.
El-Sayed NS; Miyake T; Shirazi AN; Park SE; Clark J; Buchholz S; Parang K; Tiwari R
Molecules; 2018 Jun; 23(7):. PubMed ID: 29966296
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
36. Systemic Administration of siRNA via cRGD-containing Peptide.
Huang Y; Wang X; Huang W; Cheng Q; Zheng S; Guo S; Cao H; Liang XJ; Du Q; Liang Z
Sci Rep; 2015 Aug; 5():12458. PubMed ID: 26300278
[TBL] [Abstract][Full Text] [Related]
37. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J
Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738
[TBL] [Abstract][Full Text] [Related]
38. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
[TBL] [Abstract][Full Text] [Related]
39. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
Chen G; Wang Y; Xie R; Gong S
J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
[TBL] [Abstract][Full Text] [Related]
40. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
